help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-1244
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamuro, M.
Right arrow Articles by Ogawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamuro, M.
Right arrow Articles by Ogawa, H.
Endocrinology Vol. 147, No. 3 1314-1321
Copyright © 2006 by The Endocrine Society

Direct Effects of Aldosterone on Cardiomyocytes in the Presence of Normal and Elevated Extracellular Sodium

Megumi Yamamuro, Michihiro Yoshimura, Masafumi Nakayama, Koji Abe, Makoto Shono, Satoru Suzuki, Tomohiro Sakamoto, Yoshihiko Saito, Kazuwa Nakao, Hirofumi Yasue and Hisao Ogawa

Department of Cardiovascular Medicine (Me.Y., Mi.Y., M.N., K.A., M.S., S.S., T.S., H.O.), Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan; First Department of Internal Medicine (Y.S.), Nara Medical University, Nara 634-8521, Japan; Department of Medicine and Clinical Science (K.N.), Kyoto University Graduate School of Medicine, Kyoto 606-8501, Japan; and Division of Cardiology (H.Y.), Kumamoto Aging Research Institute, Kumamoto 860-8518, Japan

Address all correspondence and requests for reprints to: Michihiro Yoshimura, Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan. E-mail: bnp{at}kumamoto-u.ac.jp.

It is now recognized that aldosterone is potentially cardiotoxic, although its local effects in the heart are not well understood. We examined the effects of aldosterone on cultured neonatal rat cardiomyocytes in the presence of normal and elevated extracellular Na+ ([Na+]o). We evaluated the intracellular volume of cardiomyocytes in the presence of normal (141 mEq/liter) and elevated (146 mEq/liter) [Na+]o by measuring cell size. Intracellular Na+ was measured using sodium-binding-benzofuran-isophthalate as a fluorescent sodium indicator, and cardiac hypertrophy was assessed using B-type natriuretic peptide transcription and 3H-leucine incorporation. Cardiomyocytes shrank in the presence of 146 mEq/liter Na+ due to the increased extracellular osmolarity at early phase. Aldosterone (10–7 mol/liter) mitigated the shrinkage by stimulating Na+ uptake by the cells. This effect of aldosterone was blocked by SM 20220, a Na+/H+ exchanger 1 (NHE1) inhibitor, but not by eplerenone, a mineralocorticoid receptor blocker. Seventy-two hours of exposure to aldosterone in the presence of 146 mEq/liter Na+ led to increases in cardiomyocyte size, 3H-leucine incorporation, and B-type natriuretic peptide and NHE1 transcription that were significantly greater than were seen in the presence of 141 mEq/liter Na+. All but the last were blocked by either eplerenone or SM 20220; the increase in NHE1 transcription was blocked only by eplerenone. Aldosterone exerts a beneficial effect via NHE1 to block cardiomyocyte shrinkage in the presence of elevated [Na+]o at early phase, but long-time exposure to aldosterone in the presence of elevated [Na+]o leads to cardiomyocyte hypertrophy via genomic effects mediated by the mineralocorticoid receptor.




This article has been cited by other articles:


Home page
HypertensionHome page
L. Michea, A. Villagran, A. Urzua, S. Kuntsmann, P. Venegas, L. Carrasco, M. Gonzalez, and E. T. Marusic
Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats
Hypertension, August 1, 2008; 52(2): 295 - 300.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. S. Hwang, G. Cirrincione, D. P. Thomas, R. J. McCormick, and M. O. Boluyt
Aldosterone Antagonism Fails to Attenuate Age-Associated Left Ventricular Fibrosis
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Susic, J. Varagic, J. Ahn, L. Matavelli, and E. D. Frohlich
Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H175 - H179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society